RAF1 and breast carcinoma: The present work provides a novel extracted peptide, H-P, which can modulate the Raf-1 signaling pathway, the autophagic machinery, and the expression of NF-kB effectors in breast cancer cells without any cytotoxic effect in the normal mammary cells.